Skip to main content
IDWeek 2021 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.

Maheen Abidi, MD

Assistant Professor of Medicine
University of Colorado, CO, United States

Maheen Abidi, MD, is an Assistant Professor of Medicine and Transplant Infectious Disease Faculty at the University of Colorado Denver. Dr. Abidi received her medical degree from Dow University of Health Sciences in Karachi, Pakistan. She completed an Internal Medicine Residency at Michael Reese Hospital in Chicago, IL, an Infectious Disease Fellowship at the University of Rochester in Rochester, NY, a Geriatrics Fellowship at Oregon Health Sciences University in Portland, OR, and a Transplant Infectious Disease Fellowship at Mayo Clinic College of Medicine in Rochester, MN. Dr. Abidi is a current recipient of an NIH K23 Mentored Patient-Oriented Research Career Development Award (2021-2026), investigating the relationship of CMV immune reconstitution with Frailty and Cognitive Function in Older Kidney Transplant recipients. She is currently investigating CMV immune reconstitution in High-Risk Hematopoietic Cell Transplant Recipients on Letermovir prophylaxis, funded by The Colorado Clinical and Translational Sciences Institute (CCTSI) and Merck Investigator Studies Program (MISP). Dr. Abidi is passionate about the care of Transplant recipients with infectious complications and is an Executive Committee member of the Infectious Disease Community of Practice of the American Transplant Congress (ATC IDCOP), Co-Chair of the ATC IDCOP Older Adult workgroup, and a Steering Committee member of the American Society of Transplantation and Cellular Therapy, Special Interest Group Transplant Infectious Disease (ASTCT SIG ID). Dr. Abidi has worked with the ASTCT Covid-19 workgroup to develop guidelines for the management of Covid-19 in HCT and Cellular Therapy recipients and ASH-ASTCT Covid-19 vaccine FAQs. She serves as an ad hoc reviewer of Transplantation, Transplant Infectious Disease, OFID, Bone Marrow Transplantation, and Mycoses.

Merck (Individual(s) Involved: Self): Grant/Research Support

Presentation(s):